ImmunoACT, an IIT-Bombay spin-off backed by Hyderabad-based Laurus Labs, is testing a new gene-therapy treatment for cancer, which they claim would not only cure the disease, but also costs one-tenth
Representative image
First Published: Jun 12 2022 | 9:38 AM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com